Treatment of bronchorrhea by corticosteroids in a case of bronchioloalveolar carcinoma producing CA19-9

被引:13
|
作者
Nakajima, T [1 ]
Terashima, T [1 ]
Nishida, J [1 ]
Onoda, M [1 ]
Koide, O [1 ]
机构
[1] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Internal Med, Chiba 2728513, Japan
关键词
lung cancer; respiratory failure; prednisolone;
D O I
10.2169/internalmedicine.41.225
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A case of gastrointestinal cancer-associated antigen (CA19-9)-positive bronchioloalveolar carcinoma accompanied by bronchorrhea and respiratory failure successfully treated with corticosteroids is reported. The patient was treated with pulse methylprednisolone at a dose of 1,000 mg/day for three days, followed by oral prednisolone (60 mg/day). Within 2 days, the sputum volume decreased from >100 ml/day to 20 ml/day and it was finally controlled to 010 ml/day. The reduction in the sputum volume was associated with alleviation of dyspnea and hypoxemia. The levels of CA19-9 in the serum and the sputum were extremely high and an immunocytochemical study showed that the tumor cells were stained by CA19-9 antibody. This case demonstrates the therapeutic value of corticosteroids in the treatment of bronchorrhea in subjects with bronchioloalveolar carcinoma.
引用
收藏
页码:225 / 228
页数:4
相关论文
共 50 条
  • [31] The Prognostic Relevance of Preoperative CEA and CA19-9 for Ampulla of Vater Carcinoma
    Matsui, Satoshi
    Yamamoto, Yusuke
    Okamura, Yukiyasu
    Ito, Takaaki
    Ashida, Ryo
    Ohgi, Katsuhisa
    Yamada, Mihoko
    Otsuka, Shimpei
    Uesaka, Katsuhiko
    Sugiura, Teiichi
    ANTICANCER RESEARCH, 2022, 42 (06) : 3169 - 3176
  • [32] Preoperative CA19-9 and GGT ratio as a prognostic indicator in ampullary carcinoma
    Rui-Qiu Chen
    Zhi-Lei Zhang
    Yu-Ming Jia
    Rui-Xiang Chen
    Li Peng
    BMC Gastroenterology, 23
  • [33] CA50 AS A SERUM MARKER FOR PANCREATIC-CARCINOMA - COMPARISON WITH CA19-9
    PASQUALI, C
    SPERTI, C
    DANDREA, AA
    COSTANTINO, V
    FILIPPONI, C
    PEDRAZZOLI, S
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (07) : 1042 - 1043
  • [34] COMBINED ASSAY OF SERUM LEVELS OF CA125 AND CA19-9 IN ENDOMETRIAL CARCINOMA
    TAKESHIMA, N
    SHIMIZU, Y
    UMEZAWA, S
    HIRAI, Y
    CHEN, JT
    FUJIMOTO, I
    YAMAUCHI, K
    HASUMI, K
    GYNECOLOGIC ONCOLOGY, 1994, 54 (03) : 321 - 326
  • [35] CA19-9 - A PROMISING TUMOR-MARKER FOR PANCREATIC-CARCINOMA
    SAKAHARA, H
    ENDO, K
    NAKAJIMA, K
    HIDAKA, A
    NAKASHIMA, T
    OHTA, H
    TORIZUKA, K
    NAITO, A
    SUZUKI, T
    JOURNAL OF NUCLEAR MEDICINE, 1984, 25 (05) : P9 - P9
  • [36] Urinary Level of CA19-9 as a Tumor Marker in Urothelial Carcinoma of the Bladder
    Pal, Keya
    Roy, Suparna
    Mondal, Samim Ali
    Chatterjee, Uttara
    Tiwari, Punit
    Bera, Malay
    UROLOGY JOURNAL, 2011, 8 (03) : 203 - 208
  • [37] The Role of CA19-9 in Predicting Tumour Resectability in Carcinoma Head of Pancreas
    Pandiaraja, Jayabal
    Viswanathan, Subramanian
    Antomy, Thomas Babu
    Thirumuruganand, Sathyamoorthy
    Kumaresan, Dhandapani Subramanian
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2016, 10 (03) : PC6 - PC9
  • [38] CA19-9 as a Predictor of Worse Clinical Outcome in Medullary Thyroid Carcinoma
    Alencar, Renata
    Kendler, Daniel Barretto
    Andrade, Fernanda
    Nava, Carla
    Bulzico, Daniel
    de Noronha Pessoa, Cencita Cordeiro
    Corbo, Rossana
    Vaisman, Fernanda
    EUROPEAN THYROID JOURNAL, 2019, 8 (04) : 186 - 191
  • [39] RECTAL MUCOSAL CONCENTRATIONS OF CA19-9 AND CEA IN COLORECTAL-CARCINOMA
    AFDHAL, NH
    DUFFY, MJ
    WALSH, V
    ODONOGHUE, DP
    GASTROENTEROLOGY, 1987, 92 (05) : 1289 - 1289
  • [40] Raised CA19-9 and CEA have prognostic relevance in gallbladder carcinoma
    Sachan, Ashish
    Saluja, Sundeep Singh
    Nekarakanti, Phani Kumar
    Nimisha
    Mahajan, Bhawna
    Nag, Hirdaya H.
    Mishra, Pramod K.
    BMC CANCER, 2020, 20 (01)